Clover Biopharmaceuticals, Ltd. 三葉草生物製藥有限公司

Pay for financial year ended 2023-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Ambrosino, Donna Marie NED 176 731 907
2 Clemens, Ralf Leo NED 176 1,309 1,485
3 Farrow, Jeffrey (1962) INED 254 2,942 3,196
4 Leggett, Thomas (1977) INED 367 2,942 3,309
5 Liang, Joshua G 梁果 CEO 4,387 13,003 17,390
6 Liang, Peng (1961) 梁朋 Ch, Fdr 2,805 3,024 5,829
7 Liao, Xiang (1965) 廖想 INED 317 2,942 3,259
8 Wang, Xiaodong (1963) 王曉東 NED 240 2,942 3,182
9 Wu, Xiaobin (1962) 吳曉濱 INED 338 2,942 3,280
Total 1,868 7,192 0 0 32,777 41,837

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,168 4,393 0 0 18,199 23,760 Report
2023-12-31 1,868 7,192 0 0 32,777 41,837 Report
2022-12-31 2,588 12,718 0 0 38,475 53,781 Report
2021-12-31 2,322 11,106 0 0 11,356 24,784 Report
Total 7,946 35,409 0 0 100,807 144,162

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top